Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine &bgr;-3 adrenergic receptor agonists

Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine &bgr;-3 adrenergic receptor agonists

US Patent 6506901 · Granted Jan 14, 2003

Estimated economic value: $538,292,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Riluzole prodrugs and their use2025
HPK1 antagonists and uses thereof2025
Prodrugs of riluzole and their method of use2024
Prodrugs of CGRP antagonists2024
Riluzole prodrugs and their use2024
HPK1 antagonists and uses thereof2024
MAP kinase modulators and uses thereof2023
Prodrugs of riluzole and their method of use2022
Sting agonists2021
MAP kinase modulators and uses thereof2021
Prodrugs of riluzole and their method of use2020
Antibody-recruiting molecules for the treatment of cancer2020